首页> Melanoma research> S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma

S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma

导出原文传递

翻译打印收藏纠错

第一作者： Abusaif,S.

作者： Abusaif,S. ^[1] ; Jradi,Z. ; Held,L. ; Pflugfelder,A. ; Weide,B. ; Meier,F. ; Garbe,C. ; Eigentler,T.K.

作者单位： Department of Dermatology, Skin Cancer Program, Liebermeisterstrasse 20, 72076 Tübingen, Germany ^[1]

关键词 Lactate dehydrogenase Metastatic melanoma Response Evaluation Criteria In Solid Tumors S100B Vemurafenib

发布时间 2014-01-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Melanoma research

2013年23卷5期

396-401页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Melanoma research

2013年23卷5期

396-401页

检索历史清除

S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma

Melanoma research

相似文献

同项目论文

Melanoma research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma

Melanoma research

相似文献

同项目论文

Melanoma research

相关期刊

检索历史清除